Page 43 - Development Command News Today : Breaking News, Live Updates & Top Stories | Vimarsana

  TORONTO -- In the middle of the COVID-19 pandemic, researchers in Saskatoon are suiting up for another fight. They’re part of a worldwide effort to create what could be a holy grail: a universal vaccine that might be able to work against all future coronavirus-related viruses. It’s like fire insurance, Volker Gerdts, director and CEO of the Vaccine and Infectious Disease Organization at the University of Saskatchewan, told CTV News. “Hopefully you will never use it. Hopefully you wasted that money,” Gerdts said. “But when you have a fire, when a new disease br...

FALLS CHURCH, Va. When the Navy Medicine 101 pilot program was initiated in 2020 it was little surprise that Lt. Cmdr. Robert Bartholomew was selected as its architect and first course director. Since 2018, the Medical Service Corps officer has served as the Plans, Operations and Medical Intelligence (POMI) course director and instructor for operational readiness and strategic management at both Naval Medical Leader and Professional Development Command (NMLPDC) and the Uniformed Services University. And for anyone being welcomed into Navy medical life or transitioning to an operational medici...

Argonne's Advanced Photon Source guided the development of new COVID-19 vaccine now in trials Human clinical trials have begun on a new vaccine candidate that may protect against not only SARS-CoV-2, the virus that causes COVID-19, but against at least two of the variants emerging around the world. The development of this new vaccine was guided by structural information on the virus obtained at the Advanced Photon Source (APS), a U.S. Department of Energy (DOE) Office of Science User Facility at DOE's Argonne National Laboratory, and other light sources. Trials are taking place at the Walter ...

Cellphire Therapeutics Names Michael Gaffney as Company's New CEO News provided by Share this article Share this article ROCKVILLE, Md., April 20, 2021 /PRNewswire/ -- Cellphire Therapeutics, Inc., a biotechnology company developing next-generation platelet-based hemostatic therapeutics for application across multiple medical indications, announced today that Michael Gaffney has joined the company as Chief Executive Officer, effective immediately. Mr. Gaffney brings deep health sector insight, extensive operational experience, and proven strategy and capital markets expertise to Cellphire. H...

3 DETROIT ARSENAL, Mich — The United Kingdom was the first adversary of the United States, but in modern history they have become one of its closest allies. U.S. and U.K. forces have stood side-by-side in both World Wars and in many other conflicts since the Revolutionary War and the War of 1812. Both countries strive to maintain their military alliance through close cooperation. One of those opportunities presented itself when Chris Bushell, Director General Land for the U.K. Ministry of Defence, visited the Detroit Arsenal to meet with U.S. Army Tank-automotive and Armam...